ORASURE TECHNOLOGIES INC (OSUR) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:OSUR • US68554V1089

2.71 USD
-0.02 (-0.73%)
At close: Feb 6, 2026
2.71 USD
0 (0%)
After Hours: 2/6/2026, 4:30:02 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to OSUR. OSUR was compared to 186 industry peers in the Health Care Equipment & Supplies industry. OSUR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. OSUR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year OSUR has reported negative net income.
  • OSUR had a negative operating cash flow in the past year.
  • OSUR had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: OSUR reported negative operating cash flow in multiple years.
OSUR Yearly Net Income VS EBIT VS OCF VS FCFOSUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

  • OSUR's Return On Assets of -14.24% is in line compared to the rest of the industry. OSUR outperforms 58.06% of its industry peers.
  • The Return On Equity of OSUR (-16.64%) is better than 62.90% of its industry peers.
Industry RankSector Rank
ROA -14.24%
ROE -16.64%
ROIC N/A
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
OSUR Yearly ROA, ROE, ROICOSUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

  • OSUR has a Gross Margin of 40.41%. This is in the lower half of the industry: OSUR underperforms 67.20% of its industry peers.
  • In the last couple of years the Gross Margin of OSUR has declined.
  • OSUR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
OSUR Yearly Profit, Operating, Gross MarginsOSUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • OSUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, OSUR has more shares outstanding
  • Compared to 5 years ago, OSUR has more shares outstanding
  • The debt/assets ratio for OSUR has been reduced compared to a year ago.
OSUR Yearly Shares OutstandingOSUR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OSUR Yearly Total Debt VS Total AssetsOSUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • OSUR has an Altman-Z score of 1.89. This is not the best score and indicates that OSUR is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 1.89, OSUR is in line with its industry, outperforming 59.68% of the companies in the same industry.
  • A Debt/Equity ratio of 0.00 indicates that OSUR is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.00, OSUR is in the better half of the industry, outperforming 75.27% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.89
ROIC/WACCN/A
WACC10.09%
OSUR Yearly LT Debt VS Equity VS FCFOSUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 7.03 indicates that OSUR has no problem at all paying its short term obligations.
  • OSUR's Current ratio of 7.03 is amongst the best of the industry. OSUR outperforms 86.02% of its industry peers.
  • A Quick Ratio of 6.20 indicates that OSUR has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 6.20, OSUR belongs to the best of the industry, outperforming 87.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.03
Quick Ratio 6.2
OSUR Yearly Current Assets VS Current LiabilitesOSUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The earnings per share for OSUR have decreased strongly by -633.33% in the last year.
  • The Revenue for OSUR has decreased by -43.95% in the past year. This is quite bad
  • Measured over the past years, OSUR shows a small growth in Revenue. The Revenue has been growing by 3.75% on average per year.
EPS 1Y (TTM)-633.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
Revenue 1Y (TTM)-43.95%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-32.14%

3.2 Future

  • The Earnings Per Share is expected to grow by 25.37% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, OSUR will show a decrease in Revenue. The Revenue will decrease by -4.62% on average per year.
EPS Next Y-239.35%
EPS Next 2Y-72.67%
EPS Next 3Y-41.36%
EPS Next 5Y25.37%
Revenue Next Year-38.37%
Revenue Next 2Y-20.05%
Revenue Next 3Y-11.49%
Revenue Next 5Y-4.62%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OSUR Yearly Revenue VS EstimatesOSUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
OSUR Yearly EPS VS EstimatesOSUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for OSUR. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OSUR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OSUR Price Earnings VS Forward Price EarningsOSUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OSUR Per share dataOSUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

  • A cheap valuation may be justified as OSUR's earnings are expected to decrease with -41.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-72.67%
EPS Next 3Y-41.36%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • OSUR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ORASURE TECHNOLOGIES INC

NASDAQ:OSUR (2/6/2026, 4:30:02 PM)

After market: 2.71 0 (0%)

2.71

-0.02 (-0.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05
Earnings (Next)02-23
Inst Owners90.28%
Inst Owner Change0.21%
Ins Owners5.58%
Ins Owner Change0.09%
Market Cap194.39M
Revenue(TTM)125.70M
Net Income(TTM)-60.24M
Analysts80
Price Target4.59 (69.37%)
Short Float %5.88%
Short Ratio5.76
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.19%
Min EPS beat(2)-24.34%
Max EPS beat(2)1.96%
EPS beat(4)1
Avg EPS beat(4)-41.25%
Min EPS beat(4)-142.2%
Max EPS beat(4)1.96%
EPS beat(8)4
Avg EPS beat(8)-77.07%
EPS beat(12)8
Avg EPS beat(12)182.53%
EPS beat(16)9
Avg EPS beat(16)134.8%
Revenue beat(2)1
Avg Revenue beat(2)-3.97%
Min Revenue beat(2)-8.84%
Max Revenue beat(2)0.89%
Revenue beat(4)2
Avg Revenue beat(4)-1.85%
Min Revenue beat(4)-8.84%
Max Revenue beat(4)0.89%
Revenue beat(8)6
Avg Revenue beat(8)-0.34%
Revenue beat(12)10
Avg Revenue beat(12)7.45%
Revenue beat(16)14
Avg Revenue beat(16)8.57%
PT rev (1m)0%
PT rev (3m)-25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.89%
EPS NY rev (1m)0%
EPS NY rev (3m)0.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-15.19%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.55
P/FCF N/A
P/OCF N/A
P/B 0.54
P/tB 0.64
EV/EBITDA N/A
EPS(TTM)-0.8
EYN/A
EPS(NY)-0.78
Fwd EYN/A
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)-0.56
OCFYN/A
SpS1.75
BVpS5.05
TBVpS4.23
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.24%
ROE -16.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.41%
FCFM N/A
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
F-Score2
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 36.29%
Cap/Sales 2.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.03
Quick Ratio 6.2
Altman-Z 1.89
F-Score2
WACC10.09%
ROIC/WACCN/A
Cap/Depr(3y)167.19%
Cap/Depr(5y)244.45%
Cap/Sales(3y)7.03%
Cap/Sales(5y)11.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-633.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
EPS Next Y-239.35%
EPS Next 2Y-72.67%
EPS Next 3Y-41.36%
EPS Next 5Y25.37%
Revenue 1Y (TTM)-43.95%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-32.14%
Revenue Next Year-38.37%
Revenue Next 2Y-20.05%
Revenue Next 3Y-11.49%
Revenue Next 5Y-4.62%
EBIT growth 1Y-539.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-91.42%
EBIT Next 3Y-4.37%
EBIT Next 5Y25.91%
FCF growth 1Y-157.36%
FCF growth 3YN/A
FCF growth 5Y117%
OCF growth 1Y-148.56%
OCF growth 3YN/A
OCF growth 5Y22.81%

ORASURE TECHNOLOGIES INC / OSUR FAQ

What is the ChartMill fundamental rating of ORASURE TECHNOLOGIES INC (OSUR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to OSUR.


What is the valuation status of ORASURE TECHNOLOGIES INC (OSUR) stock?

ChartMill assigns a valuation rating of 0 / 10 to ORASURE TECHNOLOGIES INC (OSUR). This can be considered as Overvalued.


Can you provide the profitability details for ORASURE TECHNOLOGIES INC?

ORASURE TECHNOLOGIES INC (OSUR) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for OSUR stock?

The Earnings per Share (EPS) of ORASURE TECHNOLOGIES INC (OSUR) is expected to decline by -239.35% in the next year.